Global Liquid Biopsy Market Research Tools, Services and Diagnostics Forecast Report From 2017-2022

A fresh report has been added to the wide database of Market Research Hub (MRH) titled “Global Liquid Biopsy Market Research Tools, Services and Diagnostics” offers a detailed synopsis of this industry and discusses the major factors affecting the growth. The impact on the market over the next few years has also been discussed at length in this study. It further forecasts the size and valuation of the liquid biopsy market for the forthcoming years.


Request Free Sample Report @


Report Highlights:


  • The global liquid biopsy market should reach $4.5 billion by 2022 from $1.5 billion in 2017 at a compound annual growth rate (CAGR) of 24.2%, from 2017 to 2022.
  • The global non-cancer market is expected to grow from $1.3 billion in 2017 to $2.6 billion in 2022 at a CAGR of 15.2% for the period 2017-2022.
  • The global cancer market is expected to grow from $229.3 million in 2017 to $1.9 billion in 2022 at a CAGR of 52.4% for the period 2017-2022.

Report Includes:

  • An overview of the global markets for liquid biopsy research tools, services, and diagnostics
  • Analyses of global market trends, with data from 2015 and 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Coverage of how these technologies can reduce invasive tumor biopsies, drive early cancer detection, and support precise drug administration
  • Detailed analysis of liquid biopsy workflow technologies, biomarker classes, sample types, and research tools reagents
  • Breakdowns of the market by product, product type, application, end use industry, technology, and indication
  • Evaluation of the market’s dynamics, specifically growth drivers, restraints, and opportunities
  • Profiles of major players in the industry

Report Scope:

The scope of the report includes liquid biopsy technologies, applications, industry sub segments, biomarker technologies, major funding initiatives, patents and companies. The market sizes for liquid biopsy diagnostics are given for the years 2015, 2016, 2017 (estimated) and 2022 (forecasted).

This report reviews liquid biopsy biomarkers and technologies and provides background on why liquid biopsy is increasingly viewed as a replacement for, or a companion to, tissue biopsy. It then discusses several of the significant large-scale research initiatives that are contributing to liquid biopsy development. Market driving forces are also discussed.

The structure of several important industry subsectors is reviewed, as well as major industry acquisitions and strategic alliances from January 2016 through July 2017.Industry subsectors analyzed include next-generation sequencing(NGS) instruments, droplet digital PCR, target enrichment and amplification, single-cell DNA polymerase, prenatal screening, liquid biopsy, direct to consumer, and clinical laboratory.

The market for liquid biopsy diagnostics is analyzed in depth. The market is analyzed by application (cancer, reproductive health, transplant), biomarker type (nucleic acids, cells, extracellular vesicles, proteins), analysis platform (microarray, NGS, PCR, proteomics and other), analysis purpose (screening/early detection, diagnosis, therapy guidance, monitoring) and geography (North America, Europe, Asia-Pacific, Rest of World).

Market data cover the years 2015, 2016, 2017 (estimated) and 2022 (forecasted).

More than 165 companies in the liquid biopsy industry are profiled in this report.

BCC Research provides a summary of the main industry acquisitions and strategic alliances from January 2016 through July 2017, including key alliance trends.

Browse Full Report with TOC @

Table of Content:

Chapter 1: Introduction

Study Goals and Objectives

Reasons for Doing This Study

Scope of Report

Information Sources


Geographic Breakdown

Analyst’s Credentials

Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Overview



Growth Driving Forces

Key Trends


Chapter 4: Technology Background

Liquid Biopsy Biomarkers

Cancer Genomics

Noninvasive Prenatal Testing

Circulating Tumor Cell Technologies

CTC Workflow

Cell Isolation Technologies

CTC Sample Preparation Technologies

CTC Downstream Analysis Technologies

Comparison of Liquid Biopsy with Conventional Biopsy

Cancer Testing

Prenatal Testing



Enquire about this report @

About Market Research Hub:

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of biotechnology research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients and customers.

Contact Us:

90 State Street,

Albany, NY 12207,

United States

Toll Free: 800-998-4852 (US-Canada)



Read Industry News at –


%d bloggers like this: